Skip to main content
. 2023 Feb 1;10(2):181. doi: 10.3390/bioengineering10020181

Table 1.

Study participants tabulated by the training, validation, and test sets.

Data Partitions Number of MRIs Number of Patients Age (Mean ± SD) Gender Diagnosis ††
Training set 3199 841 76 ± 7 42% F, 58% M 29% CN, 54% MCI, 17% AD
Validation set 117 30 75 ± 6 30% F, 70% M 21% CN, 59% MCI, 20% AD
Test set 114 30 77 ± 7 33% F, 67% M 27% CN, 47% MCI, 26% AD

F: female; M: male. †† CN: cognitively normal; MCI: mild cognitive impairment; AD: Alzheimer’s disease.